FRCA Notes


Bone Cement Implantation Syndrome


  • BCIS is a potentially fatal complication of orthopaedic surgery involving pressurised bone cement

  • BCIS occurs in 20% of cemented arthroplasties, although only 0.5 - 1.7% of these are Grade 3

  • Reported incidence (any grade) by procedure:
    • Cemented hip: 15 - 47%
    • Cemented knee: 28 - 71%
    • Cemented shoulder: 16%
    • Uncemented hip: 0 - 22%

  • BCIS also occurs in uncemented arthroplasty but is less severe, with no Grade 3 cases reported in uncemented procedures
  • ~6x more common in trauma than elective surgery

  • Intra-operative mortality 0.05% for THR vs 0.17% for hemiarthroplasty


Patients at high risk
ASA III or IV
Pulmonary hypertension or systemic hypertension
Significant cardiac or pulmonary disease
Male gender
Increasing age
Drugs: diuretics, warfarin
Osteoporosis or bony metastases
Primary lung cancer or lung metastases
Hip fracture (trauma) surgery

  • Cardiovascular disease such as atherosclerosis, angina, heart failure or use of ACE-I/β-blockers are not predictive of Grade 2 or 3 BCIS

Theoretical models

  • The embolic model describes embolization of medullary contents into the circulation by the presence of expanding cement in the intramedullary space
    • Such emboli include air, fat, marrow, cement, bone particles and fibrin/platelet aggregates
    • Right atrial aspirates are predominantly fat (cement particles have not been found)
    • Raised intramedullary pressure also occurs with uncemented prostheses, explaining BCIS in uncemented arthroplasty
    • Osteoporotic bone is more prone to embolisation during canal pressurisation
    • Greater embolic load correlates with greater haemodynamic and respiratory compromise
  • These contents are embolised to the pulmonary and/or coronary circulations, leading to:
    • Mechanical effects of emboli
    • Local mediator release increasing PVR

  • The multimodal model is used to account for the fact that the degree of embolisation:
    • Correlates poorly with the extent of hypoxia and hypotension
    • Cannot alone account for all the features of BCIS
  • It describes increased complement (C3a and C5a) levels and raised plasma histamine concentrations in response to the methyl-methacrylate cement
  • These mediators cause increased PVR, V/Q mismatch, hypoxia, RV failure and cardiogenic shock
  • Direct vasodilatation by methyl-methacrylate monomer is unlikely, as plasma concentrations are too low to cause systemic effects

Pathophysiological effects

  • The main pathophysiological effects of BCIS are:

    1. Hypoxia
      • Increased PA pressure (increased PVR)
      • V/Q mismatch

    2. Hypotension
      • RV dilation occurs
      • Causes shifting of interventricular septum into LV
      • This reduces LV compliance, LV filling and thus cardiac output

Timing

  • Features of BCIS typically occur at the time of bone cementation and prosthesis insertion
  • Highest-risk moments for embolisation: reaming, cementation/prosthesis insertion and hip relocation
  • It can, however, occur:
    • Before cementation e.g. during femoral reaming
    • After cementation e.g. during joint reduction and limb tourniquet deflation

Features

  • Classically results in a combination of:
    • Arterial hypoxaemia
    • Cardiovascular disturbance, typically:
      • Hypotension
      • Raised PVR and resultant reduction in RV ejection fraction
      • Also arrhythmias, cardiogenic shock or cardiac arrest
    • Loss of consciousness
  • Heart rate rises, but other variables (ETCO2, PA pressure, cardiac output) have not been shown to reliably detect BCIS; SBP and SpO2 are the key monitored variables

Classification

Feature Grade 1 Grade 2 Grade 3
Incidence ~20% 3-5% ~1%
SpO2 <94% <88% -
Systolic BP fall >20% >40% CV collapse
MAP fall >15% >30% CV collapse
Loss of consciousness No Yes Cardiac arrest
30-day mortality 9.3% 35% 88%
1-year mortality 30% 48% 94%


General

  • Identify high-risk patients during team brief
  • Discuss alternate surgical strategies, e.g. uncemented fixation (lower severity of BCIS) in high-risk patients
  • Use of a 'Cement Curfew', which starts at cement mixing and ends when the hip is relocated
  • Closed-loop communication between surgeon and anaesthetist during high-risk stages

Anaesthetic

  • Euvolaemia; avoid intravascular volume depletion
    • Goal-directed fluid therapy reduced Grade 2 BCIS in THR
  • Ensure good cardiac output prior to cement insertion with SBP within 20% of pre-operative value
  • Increase FiO2 at the time of cementation
  • Measure BP every 2.5mins during cement curfew (if no invasive BP monitoring)
  • Neuraxial anaesthesia (alone or with GA) is associated with lower BCIS incidence than GA alone

Surgical technique

Femoral intramedullary canal Cement-associated
Lavage before cementing
(High-pressure, high-volume, pulsatile)
Bone - vacuum cementing technique
Depressurising via suction catheter Retrograde insertion
Brushing and drying of canal Use of low-viscosity cement

  • Third-generation cementing (vacuum mixing, lavage, retrograde insertion, pressurisation with canal decompression/suction) reduces embolic events and cardiorespiratory disturbance, and is preferred

  • BCIS is a time-limited phenomenon and therefore treatment is supportive and aggressive
  • PA pressures usually normalise within 24hrs
  1. Secure airway

  2. Administer 100% oxygen

  3. Support cardiovascular physiology with:
    • Invasive monitoring e.g. arterial line, central line, CO monitoring
    • Volume resuscitation e.g. crystalloid bolus to maintain RV preload
    • Vasopressors
    • Positive inotropy e.g. β1 agonists
    • Standard ALS if cardiac arrest

  4. Consider ECMO for persistent hypoxaemia refractory to standard management